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Cytoskeletons of ADP- and thrombin-stimulated blood 
platelets 
Presence of a caldes~o~-Luke ~rotei~, ~-acti~i~ and gelsolin at different steps 
of the sti~~latio~ 
D.B. Pho, E. De&my&-es, E. Der Terra&m” and A. ~l~~~cki 
Comparative analyses of the cytoskeletons of resting and stimulated platelets point out the involvement of 
a 79 kDa ~olyp~tide in the activation step and its increased inco~ration during aggregation. It appears 
as a doublet and cross-reacts with an aut~body to chicken gizzard caId~mon, whereas no 1.50 kDa immuno~ 
reactive form was detected. a-Actinin and gelsolin were detected only in the aggre~tion step. 
1. INTRODUCTION 
Blood platetets display a remarkable reactivity 
to various stimuli and a high plasticity in their 
responses. This makes them a choice material for 
the study of cellular dynamics. 
Many of the changes observed appear to be 
mediated by actin microfiiaments and associated 
proteins [ 1 J. Isolation of the ~laments at low cen- 
trifugal forces after platelet lysis by 1@70 Triton 
X-100, foliowed by comparative analyses of the 
~ytoskeletons thus obtained is a useful approach 
for the identification of the proteins involved in 
these processes and sometimes for the discrimina- 
tion of different steps in platelet stimulation. 
By this procedure we have previously identified 
tropomyosin in the platelet cytoskeletons during 
activation as well as aggregation, which suggests a
possible dynamic role for this protein in platdets 
PI. 
We now present evidence for the presence of a 
ca~desmon-like protein with a molecular mass of 
79 kDa also throughout activation and aggrega- 
tion, whereas cr-actinia and geisolin are observed 
only during aggregation. 
2. MATERIALS AND METHODS 
Human plasma thrombin (minimum 3000 NH 
units/mg protein) was from Sigma. human 
platelet rw-actinin was a gift from Dr F. Landon 
(Biochimie Cejiulaire, ColI&ge de France, Paris); 
human piateIet gelsolin was prepared as previously 
described [3]. Antibodies raised in rabbits against 
chicken gizzard caldesmon and bovine plasma 
gelsoiin were gifts from Dr T. Hirabayashi 
(University of Tsukuba, Japan) and Dr M. CouC 
(Biochimie Cellulaire, Col&ge de France, Paris), 
respectively; antibodies against human platelet LY- 
actinin were prepared as described in [4]. Perox- 
idase conjugated anti-rabbit IgG was from Institut 
Pasteur Production (Marries, France). 
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2.2. Methods 
Porcine platelets were isolated as described [2], 
removal of contaminant red cells from the platelet 
rich plasma being achieved by centrifugation at 
190 x g. Platelet activation and aggregation, tur- 
bidimetric measurements, cytoskeleton isolation 
and SDS-polyacrylamide gel electrophoresis were 
also performed as described [2]. 
Densitometry of Coomassie blue-stained 
cytoskeletons on slab gels was carried out on a Ver- 
non PHI 5 (Paris, France). Platelet actin was used 
as a standard. Different aliquots of cytoskeleton 
solutions were electrophoresed for actin and for 
79 kDa polypeptide determinations as the ratio 
79 kDa/actin is quite low. 
For immunoblotting analyses the cytoskeletal 
proteins were electrophoretically separated on 
Fig. 1. SDS-polyacrylamide gel electrophoresis of Triton- 
insoluble cytoskeletons from resting and stimulated 
platelets. Lanes: (a) M, standards - (1) myosin heavy 
chain (200000), (2) phosphorylase b (94000), (3) bovine 
serum albumin (67000), (4) ovalbumin (43000), (5) 
carbonic anhydrase (30000), (6) trypsin inhibitor 
(20 lOO), (7) cy-lactalbumin (14400) (from Pharmacia 
electrophoresis calibration kit, except for myosin heavy 
chain); (b) resting platelets; (c) ADP-activated platelets 
(40 PM ADP + 4 mM EGTA); (d) ADP aggregated 
platelets (40,~M ADP + 380pg/ml fibrinogen + 2 mM 
Ca2+); (e) as in (d) except that Ca*+ was 10 mM; (f) 
control chicken gizzard caldesmon (C), cy-actinin (A) 
and gelsolin (G); (g) thrombin-activated platelets 
(0.4 U/ml thrombin + 4 mM EGTA); (h) thrombin- 
aggregated platelets (0.4 U/ml thrombin + 2 mM Ca*+); 
(b, a, P) 79 kDa caldesmon-like protein, cr-actinin and 
gelsolin in the cytoskeletons. A concave 525% gradient 
of polyacrylamide was used for the resolving gel. 
10% slab gels before transfer to nitrocellulose 
sheets. The primary antibodies were rabbit anti- 
chicken gizzard caldesmon or anti-human platelet 
a-actinin or anti-plasma gelsolin and the secondary 
antibody was peroxidase-labelled anti-rabbit IgG. 
3. RESULTS 
3.1. Caldesmon-like protein 
Comparison of the cytoskeletons from resting, 
activated and aggregated platelets consistently 
revealed, as early as in the activation step, the ap- 
pearance, among others, of a new polypeptide, the 
molecular mass of which was found to be 79 kDa 
(fig.1 lanes c,d,g,h). In the highly resolvent 
polyacrylamide gradient gel system, it appears as a 
doublet (fig.1). It cross-reacts with an antibody 
raised against chicken gizzard caldesmon, which 
stains no other polypeptide band in the 
cytoskeletons (fig.2, lanes c,d,g,h). 
Figy Immunoblot of platelet cytoskeletons with anti- 
chicken gizzard caldesmon IgG. (C) Chicken gizzard 
caldesmon; (b-h) platelet cytoskeletons lettered as in 
fig. 1. 
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This 79 kDa polypeptide was observed whether 
stimulation was induced by ADP or thrombin. Ag- 
gregation with ADP is usually obtained in the 
presence of 350-400 pg/ml fibrinogen. As the high 
concentration of this protein, which binds to 
platelets during aggregation, obscured the 
polypeptide patterns of the cytoskeletons we have 
also attempted to induce aggregation with ADP 
without fibrinogen by increasing the calcium con- 
centration to 10 mM. The 79 kDa band was no 
longer observable in the cytoskeletons thus ob- 
tained (not shown); this effect of calcium was con- 
firmed when aggregation was achieved with ADP 
and fibrinogen (figs le and 2e) or with thrombin 
(not shown) in the presence of the same concentra- 
tion of calcium. 
Densitometry showed that the 79 kDa polypep- 
tide/actin ratios were increased about 2-fold in the 
cytoskeletons of aggregated platelets as compared 
to those of activated platelets. This means that 
besides an increase of the actin content in these 
cytoskeletons there was also a net increase in incor- 
poration of the 79 kDa polypeptide. 
3.2. a-Actinin 
Coomassie blue staining of the cytoskeletons 
revealed that a polypeptide with the same mobility 
and hence the same molecular mass (105 kDa) as 
pure human platelet a-actinin was observed only in 
the cytoskeletons of aggregated platelets 
(fig.ld,h). It also cross-reacted strongly with 
affinity-purified anti-human platelet a-actinin 
(fig.3). This sensitive reaction detected traces of a- 
actinin in resting and activated platelet 
cytoskeletons, but both Coomassie blue and im- 
munostainings indicated that the content of this 
protein is by far larger than what could be expected 
from a general increase in cytoskeletal proteins 
(and particularly actin) in itself. These results thus 
Fig.3. Immunoblot of platelet cytoskeletons with anti- 
human 1 platelet cY-actinin IgG. (A) cy-Actinin au isoform; 
(b-h) platelet cytoskeletons lettered as in fig.1; (x) 
cleavage product from cY-actinin appearing after boiling 
samples of this product [5]. 
Fig.4. Immunoblot of platelet cytoskeletons with anti- 
plasma gelsolin IgG. (G) gelsolin; (b-h) platelet 
cytoskeletons lettered as in fig.1. 
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clearly favour the involvement of cu-actinin only in 
the aggregation step, whether the inducer was 
thrombin or ADP. 
3.3. Gelsolin 
In the cytoskeletons of aggregated platelets, a 
polypeptide having the same mobility as human 
platelet gelsolin is also observable, although the 
colour intensity of this band is weaker than that of 
a-actinin (fig. ld,h). This polypeptide cross-reacts 
with an antibody raised against plasma gelsolin 
(fig.4d,h). 
4. DISCUSSION 
Our results suggest that  79 kDa caldesmon-like 
polypeptide is involved in the formation of the 
cytoskeletons of activated as well as aggregated 
platelets. Kakiuchi et al. [6] have found that 
human platelet caldesmon was a doublet of 
147-150 kDa, similar to chicken gizzard 
caldesmon. However, these authors indicated later 
on [7] that traces of a 77 kDa polypeptide reactive 
to 150 kDa caldesmon antibody was also present. 
This caldesmon form is more widely distributed 
than caldesmonrso in a variety of cells and tissue 
types [7]. Bretscher and Lynch [8] also reported 
two classes of immunoreactive forms, 120-140 
and 71-77 kDa, of caldesmon in various cultured 
cells. All these authors detected immunostaining of 
these proteins along stress fibers and in the leading 
edge of motile cultured cells. It is thus not surpris- 
ing that a 79 kDa caldesmon-like polypeptide has 
been found as a component of stimulated platelet 
cytoskeletons. Its disappearance from the 
cytoskeletons obtained in the presence of high con- 
centration of exogenous calcium is also in keeping 
with the calcium-calmodulin dependence of its in- 
teraction with F-actin [6,9] and/or susceptibility to 
proteases [9,10]. These results on a 79 kDa 
caldesmon-like protein in platelet cytoskeletons are 
thus in agreement with those of Dingus et al. [l 11. 
Its appearance as soon as platelets are activated 
and its increased incorporation into the 
cytoskeletons during aggregation suggests it may 
play an important role in the dynamic processes of 
platelet stimulation. This may be a yet unknown 
one. It may also be the actin-linked regulation of 
120 
actin myosin interaction as described in chicken 
gizzard smooth muscle [ 121 and bovine adrenal 
medulla [ 131. The presence in the cytoskeletons of 
all the factors required for such a process,’ actin 
and myosin [ 141, tropomyosin [2,15], calmodulin 
[ 161 and the 79 kDa caldesmon-like protein is quite 
compatible with such a hypothesis. The detailed 
mechanism of this regulation, however, remains to 
be elucidated. 
Another problem to be solved is the discrepancy 
between the molecular masses determined for 
platelet caldesmon. We were not able to detect im- 
munologically any other reactive species besides 
the 79 kDa form, even in the Triton-soluble extract 
of resting platelets. Whether this latter exists as 
such or comes from an as yet undetectable 
150 kDa form in porcine platelets, in a proteolytic 
step before isolation, is still uncertain. 
Work is currently underway to investigate fur- 
ther these aspects of caldesmon biochemistry. 
Lu-Actinin has been recognized in cytoskeletons 
of stimulated platelets by its molecular mass, 
which ranges from 95 to 105 kDa with various 
researchers [ 17- 191. Nachmias et al. identified it in 
cytoskeletons of resting and activated platelets 
both by its molecular mass and immunoreactivity 
to a-actinin antibodies [ 18,20,21], but its presence 
in these cytoskeletons is probably due to platelet 
isolation at low temperature: electron microscopy 
has shown that this procedure leads to very ir- 
regularly shaped platelets and microaggregates 
linked to cold stimulation [22]. Our results are in 
agreement with those of Rotman et al. [23] based 
on molecular mass and clearly point out the in- 
volvement of a-actinin in the aggregation step. 
This is compatible with the highly organized struc- 
ture of microfilaments in aggregated platelets 
[1,24,25] and the cross-linking action of cu-actinin 
on microfilaments [26]. Nevertheless, there is a 
discrepancy with the in vitro inhibition of this ac- 
tion by calcium [19,27] and this remained 
unexplained. 
The present identification of gelsolin in the 
cytoskeletons of aggregated platelets lends support 
to the hypothesis that this actin binding protein is 
involved in the later stage of aggregation: its 
calcium-dependent severing effect [28] is thought 
to take part in the regulation of the microfilament 
reorganization when platelet aggregates condense 
and fibrin clots retract [ 11. 
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